Dow Jones

38,807.33

0.00%

Regístrate para obtener alertas en tiempo real, cartera personalizada y movimientos del mercado.

Regístrate

Inicio
Invertir
Acciones
Estados Unidos
USOTC
Alterity Therapeutics Ltd (PK) (PRNAF)
Alterity Therapeutics Ltd (PK) (PRNAF) Noticias

PRNAF

Alterity Therapeutics (PK) (PRNAF)

Alterity Therapeutics Ltd (PK)

Fecha:

Regulatory News

Text Search:

Ordernar por:

Non-Regulatory News

Showing the most relevant articles for your search:USOTC:PRNAF

1

Fecha	Hora	Fuente	Título	Símbolo	Compañía
04/03/2024	07:01	Edgar (US Regulatory)	Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16]	USOTC:PRNAF	Alterity Therapeutics Ltd (PK)
02/10/2023	07:44	Edgar (US Regulatory)	Form F-3 - Registration statement by foreign private issuers	USOTC:PRNAF	Alterity Therapeutics Ltd (PK)
31/08/2023	08:15	Edgar (US Regulatory)	Form 20-F - Annual and transition report of foreign private issuers [Sections 13 or 15(d)]	USOTC:PRNAF	Alterity Therapeutics Ltd (PK)
21/06/2023	05:09	Edgar (US Regulatory)	Report of Foreign Issuer Pursuant to Rule 13a-16 or 15d-16 (6-k)	USOTC:PRNAF	Alterity Therapeutics Ltd (PK)
31/08/2022	11:25	Edgar (US Regulatory)	Annual and Transition Report (foreign Private Issuer) (20-f)	USOTC:PRNAF	Alterity Therapeutics Ltd (PK)
26/08/2022	16:19	Edgar (US Regulatory)	Amended Statement of Beneficial Ownership (sc 13d/a)	USOTC:PRNAF	Alterity Therapeutics Ltd (PK)
03/06/2022	05:06	Edgar (US Regulatory)	Amended Report of Foreign Issuer Pursuant to Rule 13a-16 or 15d-16 (6-k/a)	USOTC:PRNAF	Alterity Therapeutics Ltd (PK)
06/01/2021	15:16	Edgar (US Regulatory)	Prospectus Filed Pursuant to Rule 424(b)(3) (424b3)	USOTC:PRNAF	Alterity Therapeutics Ltd (PK)
23/12/2020	15:07	Edgar (US Regulatory)	Securities Registration (foreign Private Issuer) (f-3)	USOTC:PRNAF	Alterity Therapeutics Ltd (PK)
16/12/2020	15:50	Edgar (US Regulatory)	Prospectus Filed Pursuant to Rule 424(b)(5) (424b5)	USOTC:PRNAF	Alterity Therapeutics Ltd (PK)
02/12/2020	15:07	Edgar (US Regulatory)	Securities Registration: Employee Benefit Plan (s-8)	USOTC:PRNAF	Alterity Therapeutics Ltd (PK)
24/11/2020	05:03	Edgar (US Regulatory)	Notice of Effectiveness (effect)	USOTC:PRNAF	Alterity Therapeutics Ltd (PK)
26/05/2020	05:16	Edgar (US Regulatory)	Report of Foreign Issuer (6-k)	USOTC:PRNAF	Alterity Therapeutics Ltd (PK)
18/04/2019	15:47	Edgar (US Regulatory)	Statement of Beneficial Ownership (sc 13d)	USOTC:PRNAF	Alterity Therapeutics Ltd (PK)
27/03/2019	05:10	Edgar (US Regulatory)	Amended Report of Foreign Issuer (6-k/a)	USOTC:PRNAF	Alterity Therapeutics Ltd (PK)
06/11/2014	09:10	Edgar (US Regulatory)	Securities Registration (ads, Immediate) (f-6ef)	USOTC:PRNAF	Alterity Therapeutics Ltd (PK)
31/10/2014	16:00	Edgar (US Regulatory)	Notification That Form 20-f Will Be Submitted Late (nt 20-f)	USOTC:PRNAF	Alterity Therapeutics Ltd (PK)
24/07/2014	14:39	Edgar (US Regulatory)	Post-effective Amendment to Registration Statement (pos Am)	USOTC:PRNAF	Alterity Therapeutics Ltd (PK)